XBiotech

(NASDAQ: XBIT)
Healthcare  |  Biotechnology
12.87 -0.145 -1.11%
Stock Price | Feb. 26, 2020, 10:23 a.m.
0 Followers
Bid: 12.78
Ask: 12.89
Prev. Close: 13.01
52 Week Low: 6.761
52 Week High: 26.4
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

XBiotech Inc is an US based clinical-stage biopharmaceutical company which is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. It has developed therapeutic antibody Xilonix which is being evaluated as a monotherapy to treat advanced stages of colorectal cancer. Xilonix neutralizes a pro-inflammatory protein produced by leukocytes and other cells.

Read more Read less

Recently Viewed Tickers

Premium MicroCap Digest: Our Best In Two Years - A Must Read

1 Comments
3 years ago